The Evolving Role of Tucatinib in HER2-Positive Metastatic Breast Cancer
EP. 1: HER2-Positive mBC Emerging Treatment Landscape
By
Sara A. Hurvitz, MD
July 15th 2020
EP. 2: Currently Accepted Regimens: NCCN Guidelines
By
Sara A. Hurvitz, MD
July 15th 2020
EP. 3: HER2CLIMB FDA Approval
By
Sara A. Hurvitz, MD
July 15th 2020
EP. 4: R/R HER2+ mBC Management During COVID-19 Pandemic
By
Sara A. Hurvitz, MD
July 15th 2020
